کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1504893 | 1511006 | 2013 | 5 صفحه PDF | دانلود رایگان |

10-Hydroxycamptothecin (HCPT) as a hydrophobic anticancer drug brings many challenges in the clinical applications due to its poor water solubility and the presence of a chemically unstable lactone ring. In this work, the nanocomposites of HCPT intercalated layered double hydroxide (LDH) were prepared by a secondary intercalation method, and the encapsulated HCPT could keep the biologically active lactone form. A Zn–Al–NO3 LDH was pillared with sebacate anions by a co-precipitation method in an aqueous medium, and then HCPT was intercalated into the LDH's gallery via hydrophobic interaction in an ethanol medium. The parallel alkyl chains of perpendicularly arranged sebacate anions in the LDH gallery provide a hydrophobic space for the drug intercalation. The in vitro release kinetics of HCPT from the nanocomposites could be fitted with the pseudo-second-order kinetic model, and the diffusion of HCPT through the LDH particles played an important role in controlling the drug release. The nanocomposites can be considered as a potential drug delivery system.
Figure optionsDownload as PowerPoint slideHighlights
► The HCPT–SC–LDH composites was successfully synthesied by a secondary intercalation method.
► The encapsulated HCPT could keep the biologically active lactone structure.
► The obtained drug-LDH nanocomposite showed a good drug loading amount and obvious controlled release effect.
Journal: Solid State Sciences - Volume 16, February 2013, Pages 71–75